Rubius is pioneering Red-Cell Therapeutics™ - a new class of drugs that provide transformative treatments to patients across all major therapeutic areas

Our Story

Rubius was co-founded by Avak Kahvejian, Ph.D., Jordi Mata-Fink, Ph.D., Noubar Afeyan, Ph.D., all of Flagship VentureLabs®, the innovation foundry of Flagship. The academic co-founders are Harvey Lodish, Ph.D., and Hidde Ploegh, Ph.D., both of MIT and the Whitehead Institute for Biomedical Research.

Flagship VentureLabs is the innovation foundry of Flagship Pioneering. It is the first institution dedicated to entrepreneurial innovation, where discovery, invention and entrepreneuring are performed simultaneously by a world-class team of scientists, innovators and professional entrepreneurs. VentureLabs has used its unique, systematic approach to produce first-in-class companies based on in-house innovations. Since its founding in 2000, the VentureLabs team has founded more than 35 life science companies, including Seres Therapeutics (NASDAQ:MCRB), Syros Pharmaceuticals (NASDAQ:SYRS), Axcella Health, and Moderna Therapeutics.